Us Bancorp \De\ Theravance Biopharma, Inc. Transaction History

Us Bancorp \De\

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$8.29 - $9.92 $1,848 - $2,212	-223 Reduced 43.9%	285 $2,000
Q1 2024 May 07, 2024	SELL	$8.22 - $11.59 $7,611 - $10,732	-926 Reduced 64.57%	508 $4,000
Q4 2023 Feb 09, 2024	BUY	$8.58 - $11.4 $3,723 - $4,947	434 Added 43.4%	1,434 $16,000
Q3 2023 Nov 03, 2023	SELL	$8.38 - $10.44 $1,122 - $1,398	-134 Reduced 11.82%	1,000 $8,000
Q2 2023 Aug 09, 2023	SELL	$10.16 - $11.92 $9,550 - $11,204	-940 Reduced 45.32%	1,134 $11,000
Q1 2023 May 09, 2023	BUY	$9.87 - $11.44 $3,010 - $3,489	305 Added 17.24%	2,074 $22,000
Q3 2022 Oct 27, 2022	SELL	$8.39 - $10.22 $6,535 - $7,961	-779 Reduced 30.57%	1,769 $18,000
Q2 2022 Aug 01, 2022	SELL	$8.41 - $10.34 $243 - $299	-29 Reduced 1.13%	2,548 $23,000
Q1 2022 May 11, 2022	BUY	$8.33 - $12.96 $33 - $51	4 Added 0.16%	2,577 $25,000
Q4 2021 Feb 11, 2022	BUY	$7.42 - $11.05 $17,986 - $26,785	2,424 Added 1626.85%	2,573 $28,000
Q3 2021 Nov 10, 2021	BUY	$6.77 - $14.41 $737 - $1,570	109 Added 272.5%	149 $1,000
Q1 2021 Apr 28, 2021	SELL	$16.57 - $21.08 $1,259 - $1,602	-76 Reduced 65.52%	40 $1,000
Q4 2020 Feb 04, 2021	BUY	$14.89 - $20.16 $1,727 - $2,338	116 New	116 $2,000
Q3 2020 Nov 10, 2020	SELL	$14.79 - $22.49 $2,780 - $4,228	-188 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$20.64 - $30.69 $2,332 - $3,467	113 Added 150.67%	188 $4,000
Q3 2019 Nov 08, 2019	BUY	$16.51 - $23.78 $1,238 - $1,783	75 New	75 $1,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.